Device Makers are currently at an intersection of accelerated innovation and heightened regulatory scrutiny. Regulatory affairs stands in the center guiding operational resilience and a coherent ...

Generative AI is transforming pharma’s slowest lane —regulatory affairs — into a fast track for life-saving treatments. Bringing a new drug to market is one of the most expensive and time-consuming ...